Opioid Market Forecast: In-depth Analysis Predicts Continued Growth to $25.3 Billion by 2030

DUBLIN, Nov. 13, 2023 /PRNewswire/ — The “Opioid Market Size, Share & Trends Analysis Report By Product (IR/ Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain Relief, Anesthesia), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global opioid market size is expected to reach USD 25.3 billion by 2030, registering a CAGR of 1.4% during the forecast period. Supportive regulatory policies aid manufacturers to introduce products that may contribute to the market growth. 

Report Coverage:

  • Market lineage and growth prospects.
  • Dynamic analysis including drivers and restraints.
  • Competitive insights and market participant categorization.

Market Growth Projections:

  • Estimated Growth: Market expected to reach USD 25.3 billion by 2030.
  • Growth Rate: Anticipated CAGR of 1.4% from 2023 to 2030.

Regulatory Developments:

  • FDA Approvals: Key product approvals contributing to market growth.
  • Policy Support: Supportive regulatory environment as a significant growth driver.

Market Dynamics:

  • Postoperative Pain Management: Surge in opioid use for postoperative pain management.
  • Chronic Pain Management: High prevalence of chronic pain fuels the demand for pain relief applications.

Product Analysis:

  • ER/Long Acting Opioids: Largest market share attributed to new approvals and launches.

Application Insights:

  • Pain Relief Dominance: Chronic pain treatment remains a leading application segment.

Administration Route Trends:

  • Injectables Lead: Dominance due to their extensive use in chronic pain management and anesthesia.

Distribution Channel Analysis:

  • Retail Pharmacies at the Forefront: High dispensing rate influences market growth.

Regional Growth Outlook:

  • Asia Pacific’s Rapid Growth: Anticipated fastest growth due to an increasing geriatric population prone to chronic pain.

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Opioids Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.2. Penetration & Growth Prospect Mapping

3.3. Market Dynamics

3.4. Opioids Market Analysis Tools

Chapter 4. Opioids: Product Estimates & Trend Analysis

4.1. IR/Short Acting Opioids

4.2. ER/Long Acting Opioids

Chapter 5. Opioids: Application Estimates & Trend Analysis

5.1. Pain Relief

5.2. Anesthesia

5.3. Cough Suppression

5.4. Diarrhea Suppression

5.5. De-addiction

Chapter 6. Opioids: Route of Administration Estimates & Trend Analysis

6.1. Oral

6.2. Injectable

Chapter 7. Opioids: Distribution Channel Estimates & Trend Analysis

7.1. Hospital Pharmacy

7.2. Retail Pharmacy

Chapter 8. Opioids Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants

9.2. Market Participant Categorization

  • Purdue Pharma L.P.
  • Johnson & Johnson Services, Inc.
  • Hikma Pharmaceuticals PLC
  • Pfizer Inc.
  • AbbVie Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Grunenthal
  • Merck & Co., Inc.

For more information about this report visit https://www.researchandmarkets.com/r/m4nipx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets

Laura Wood, Senior Manager

[email protected]

 

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

 

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


Go to Source